Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Letter September 30 2025
Liberalizing Hospital Proximity Requirements for Children/Young Adults with Low Burden B-ALL Receiving Tisagenlecleucel
Research Article September 30 2025
Population-scale Analysis Reveals Germline Loss of SERPING1 (C1-Inhibitor) is a Polyphenotypic Thrombotic Disorder
Research Article September 30 2025
Outcome of Patients with Mantle Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy: A Descar-T Study By Lysa Group
Research Article September 30 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations
Research Article September 24 2025
Tumor-Specific Immune Responses and Biomarkers in pediatric High-Risk Hodgkin Lymphoma Patients
Letter September 24 2025
Age-Based Pegaspargase Dosing is Safe and Achieves Therapeutic Levels in Infants with ALL: Report from COG AALL15P1
Research Article September 18 2025
Artificial Intelligence Accelerates the Interpretation of Measurable Residual B Lymphoblastic Leukemia by Flow Cytometry
Research Article September 18 2025
Risk Biomarkers of Chronic Graft-versus-host disease in Children aged 10 years or younger and Children/adults Older than 10 years
Letter September 18 2025
Do not forget vaccinations in patients on Ig replacement
Research Article September 18 2025
Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study
Research Article September 12 2025
Induction of Moderate DNA Damage Enhances Megakaryopoiesis and Platelet Production
Research Article September 12 2025
Developing an AI-Generated Peptide Targeting Platelet-type von Willebrand Disease
Letter September 12 2025
Overall survival, conditioning, and MRD in MORPHO
Research Article September 9 2025
Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq
Review Article September 8 2025
Clinical applications of mass spectrometry in multiple myeloma
Review Article September 3 2025
The ASH Research Collaborative Sickle Cell Disease Research Network: Past, Present and Future
Research Article August 28 2025
Efficacy and Safety of Belumosudil as Compared with Best Available Therapy for the Treatment of cGVHD in the US
Research Article August 28 2025
Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura
Research Article August 27 2025
BK virus kinetics and associated cystitis/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant
Research Article August 22 2025
Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism
Research Article August 19 2025
Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies
Research Article August 14 2025
Ectopic expression of BEX genes in T-cell Acute Lymphoblastic Leukemia
Research Article August 14 2025
New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma
Research Article August 14 2025
Phase 2 Study of Relmacabtagene Autoleucel (CD19 CAR-T) for Relapsed/Refractory Mantle Cell Lymphoma in Chinese Adults
Research Article August 8 2025
Accelerating Novel Therapies for Sickle Cell Disease with RWE: ASH RC Data Hub as a Strategically Coordinated Registry Network
Letter August 5 2025
Mini-Hyper-CVD plus Venetoclax and Navitoclax for Relapsed/Refractory Acute Lymphoblastic Leukemia
Research Article August 5 2025
Safety and Efficacy of Daratumumab in Immune Thrombocytopenia
Page 4 of 4

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals